Valiant Laboratories Limited — Board Meeting, 08-08-2025: Outcome of Board Meeting

Valiant Laboratories held a board meeting on August 8, 2025, to approve its audited consolidated financial results for the quarter ended June 30, 2025. The company reported robust growth, with consolidated revenue from operations surging to ₹46.82 crore from ₹18.88 crore in the same quarter last year. Notably, Valiant Labs turned profitable, posting a net profit of ₹1.82 crore compared to a loss of ₹0.51 crore year-on-year. Basic earnings per share (EPS) stood at ₹0.42 for the quarter.